Financial Times: Drugmaker Eli Lilly has won US regulatory approval to sell a weight-loss drug in pill form, setting up a fight with rival Novo Nordisk in the market for oral obesity medicines.
…
Lilly said the pill would cost $149 a month for the lowest dose, and people with insurance coverage could get it for as little as $25 a month…